Can you guarantee that this will work for me?
No. No responsible clinic can guarantee that stem cell therapy will work for a specific patient, just as no surgeon can guarantee the result of an operation and no doctor can guarantee that a medication will work for everyone.
Each person's condition, stage, age, health and response are different. What we can guarantee is how we work: an honest medical evaluation before any commitment, a clear written plan with the price and everything included, a single cell product, allogeneic mesenchymal stem cells (MSCs) from Wharton's jelly of the umbilical cord prepared in a COFEPRIS-licensed laboratory, procedures performed with image guidance and medical monitoring, and structured follow-up after you return home. We also tell you when treatment is unlikely to help. The evidence supporting regenerative treatment is strongest in knee osteoarthritis and degenerative disc disease, where randomized trials show greater pain relief than control treatments, and results vary from patient to patient.
This guide explains why medical results cannot be guaranteed, what increases your chances of a good result and what commitments you can expect from us.
Why no medical treatment comes with a guarantee
Every medical treatment, from medications to surgery, works differently in different people. Several factors explain why:
- The condition and its stage: the same diagnosis can vary greatly between two people.
- Individual biology: age, genetics, inflammation, blood flow and healing capacity differ.
- Other health conditions: diabetes, heart disease, smoking and weight influence recovery.
- Lifestyle and rehabilitation: exercise, sleep and follow-through after treatment matter.
- Expectations: a clear, realistic goal makes success easier to recognize.
The International Society for Stem Cell Research (ISSCR) and the U.S. Food and Drug Administration (FDA) both advise patients to be cautious with clinics that guarantee results or present testimonials as proof. A guarantee in medicine is a warning sign, not a reassurance.
What the evidence shows about results
- Knee osteoarthritis: a 2024 meta-analysis of randomized controlled trials in the Journal of Orthopaedic Translation found that MSC injections reduced pain more than hyaluronic acid at 12 months and improved function.
- Degenerative disc disease: a 2026 meta-analysis of randomized trials in the Asian Spine Journal found greater pain reduction with intradiscal MSCs than with control treatments.
- Safety: a 2026 meta-analysis of IV umbilical-cord-derived MSCs in Stem Cells Translational Medicine found temporary fever as the most consistent side effect, without an increase in serious infection, thrombosis, cancer or death in controlled trials.
These results describe groups of patients. Within those groups, some people improve a great deal, some moderately and some little, which is why individual guarantees are not possible. The evaluation helps estimate where you are likely to fall, based on your condition, stage and health.
What we can commit to
1. An honest evaluation
Before you pay anything beyond the deposit, the doctor reviews your records, imaging and labs and tells you whether treatment makes sense for your condition. If the expected benefit is low or the risks outweigh it, we tell you.
2. A clear written plan
You receive a written plan listing the number of cells, the route of application, the nights at our facilities, the consultation with your doctor and the stem cell specialist, transportation and the total price. Only what is listed is included, and there are no hidden charges.
3. A single, consistent cell product
We use only allogeneic MSCs from Wharton's jelly of donated umbilical cords, obtained after healthy births with informed consent and donor screening, prepared in a COFEPRIS-licensed laboratory under Good Manufacturing Practice standards, with quality and safety testing before release.
4. Careful procedures
Joint and spine applications are performed with ultrasound or fluoroscopy guidance, and IV infusions are monitored. You stay a night at our facilities with nursing and medical care.
5. Follow-up
Our team stays in contact after treatment through calls and messages, reviews your progress and, if needed, discusses next steps, such as a second application, a PRP session or other options.
How to improve your chances of a good result
- Choose a clear goal, such as walking without knee pain or sitting comfortably at work.
- Treat the right problem: accurate imaging and diagnosis are essential.
- Address other factors: weight, blood sugar, blood pressure, sleep and smoking.
- Follow the activity plan and rehabilitation after treatment.
- Measure your progress with simple scores before and after treatment.
- Stay in contact with our team, especially in the first months.
Who tends to respond best
- Patients with mild to moderate joint degeneration or disc-related back pain.
- Patients who treat the problem earlier rather than at a very advanced stage.
- Patients who stay active and follow rehabilitation.
- Patients with good control of chronic conditions such as diabetes, high blood pressure and high cholesterol.
What happens if I do not notice improvement?
Improvement is often gradual, appearing over weeks to months. If, after a reasonable period, you notice little change, the doctor reviews your measures and discusses options openly, which may include a second application, adding PRP or rehabilitation, adjusting other parts of your care or considering a different treatment. No further treatment is recommended unless there is a medical reason for it.
Results in perspective by condition
| Condition | Typical goal | What helps the result |
|---|---|---|
| Knee or joint osteoarthritis | Less pain, better function | Earlier stage, weight management, strengthening |
| Degenerative disc disease | Less back or neck pain | Accurate diagnosis of the pain source, core exercise |
| Sports injuries | Support for healing | Rehabilitation and gradual return to sport |
| Neurological conditions | Gains in specific functions | Intensive rehabilitation, clear goals |
| Heart, kidney, metabolic conditions | Support for function and quality of life | Optimized medical care, objective tests |
| Healthy aging and energy | More energy and recovery | Sleep, exercise, nutrition |
Questions patients often ask about results
If it worked for my friend, will it work for me? Not necessarily. Your friend may have had a different condition, stage or protocol. Your evaluation is based on your own records.
Is a higher number of cells always better? No. The number of cells is chosen for the target and route; more cells do not automatically mean a better result, and in confined spaces such as a joint, too many cells can increase discomfort.
How soon will I know? Joint and spine pain often begins to ease within days to weeks, while neurological, systemic, hair and skin goals usually change over months.
Can I combine treatment with my current care? Yes. Medications, therapy and specialist follow-up continue, and they often improve the overall result.
Why testimonials are not a guarantee
Personal stories can be encouraging, and many patients share positive experiences. However, each case is different, and stories about excellent results are more likely to be shared than stories about modest ones. The most reliable way to judge your own result is to compare your measures, such as pain scores, walking distance or test results, before and after treatment.
What our patients usually receive
Based on the treatment plans our team prepares, typical protocols at Stem Cell Mexico include:
- For joints or the spine: 20 to 40 million Wharton's jelly MSCs per area by direct injection with image guidance, often with platelet-rich plasma (PRP).
- For systemic and neurological goals: IV infusion, usually 100 to 200 million cells, and in selected neurological cases an additional intrathecal application.
- One night at our facilities, the consultation with your doctor and the stem cell specialist, pre-treatment tests and ground transportation from the San Diego airport area.
Treatment plans range from about $1,800 to $9,500 USD, depending on the condition and plan.
Safety
No medical treatment is free of risk. The most common effects are temporary: fever, headache or fatigue after an IV infusion, and pain, swelling or stiffness for a few days after a local injection. Screening, sterile technique, image guidance and monitoring are part of every protocol to keep risk as low as possible.
Questions to ask during your evaluation
- What results are realistic for my condition and stage?
- What could make my result better or worse, and what can I do about it?
- How will we measure progress?
- What happens if I do not improve as expected?
Bottom line
No one can guarantee that stem cell therapy will work for a specific person, and a guarantee in medicine is a warning sign. What Stem Cell Mexico commits to is an honest evaluation, a clear written plan, a single Wharton's jelly cell product from a licensed laboratory, careful procedures and structured follow-up, with the strongest evidence in knee osteoarthritis and degenerative disc disease and results that vary between patients. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your condition, goals and medical history.
References
- International Society for Stem Cell Research (ISSCR): The ISSCR Guide to Stem Cell Treatments (opens in a new tab)
- U.S. Food and Drug Administration (FDA): Important patient and consumer information about regenerative medicine therapies (opens in a new tab)
- Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
- Rahyussalim et al. Intradiscal mesenchymal stem cell therapy for degenerative disc disease: a systematic review and meta-analysis of randomized trials. Asian Spine Journal, 2026 (opens in a new tab)
- Hum C et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026 (opens in a new tab)
